Refinitiv StreetEvents Event Transcript
E D I T E D V E R S I O N
QURE.OQ - Uniqure NV
Uniqure NV at TD Cowen Healthcare Conference
Mar 02, 2026 / 03:30PM GMT
=====================
Presentation
--------------------------------------------------------------------------------
Unidentified_1 [1]
--------------------------------------------------------------------------------
Thank you for joining us in the room and online, for, TD Cowan's 46th annual healthcare conference. I'm Joeho, one of the senior biotech analysts here on the team at TD Cowan, and it is my pleasure to have with me today CEO of Unicure, Matt Capita.
Thank you for joining us. Obviously a lot to get through, but, I think we'll start the conversation on a good note. What did we see from the phase 3 data? For Huntington's in 130, if you can take us back, obviously, six months-ish, you know how are we seeing on patient benefit versus natural history and kind of what are the highlights of the phase 3 data from your perspective?
--------------------------------------------------------------------------------
Unidentified_2 [2]

